Vaxart
VXRT
#9397
Rank
S$0.11 B
Marketcap
S$0.47
Share price
-1.62%
Change (1 day)
-44.36%
Change (1 year)

Vaxart (VXRT) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : S$0.16 Billion

According to Vaxart's latest financial reports the company's total liabilities are S$0.16 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Vaxart - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$0.14 B225.06%
2023-12-31S$44.93 M-22.5%
2022-12-31S$57.98 M27.5%
2021-12-31S$45.47 M17.81%
2020-12-31S$38.6 M18.9%
2019-12-31S$32.46 M-0.94%
2018-12-31S$32.77 M
2017-06-30S$29.45 M-17.48%
2016-06-30S$35.69 M167.63%
2015-06-30S$13.33 M-60.52%
2014-06-30S$33.78 M49.57%
2013-06-30S$22.58 M
2011-12-31S$50.62 M-26.26%
2010-12-31S$68.65 M44.22%
2009-12-31S$47.6 M45.75%
2008-12-31S$32.66 M-75.34%
2007-12-31S$0.13 B-44.09%
2006-12-31S$0.23 B-15.06%
2005-12-31S$0.27 B103.89%
2004-12-31S$0.13 B18.43%
2003-12-31S$0.11 B52.03%
2002-12-31S$75.97 M-66.66%
2001-12-31S$0.22 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NRC Health
NRC
S$0.15 B-7.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
S$4.06 M-97.60% Bahamas